NPHP3 p.Asn386Ser
c.1157A>G · rs142021049 · VCV96508
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2051 | likely benign |
|---|---|---|
| REVEL | 0.365 | indeterminate |
| SaProt | LLR -6.63 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.8 | GERP 2, phastCons 1 |
| Regional constraint | o/e 1.01 | unconstrained · MANE · 30 kb · p 0.87 · regional, not allelic |
| Overall | ||
| CADD | 20.2 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.389% | 257 |
| Admixed American | 0.192% | 522 |
| Remaining individualsnot grpmax-eligible | 0.171% | 584 |
| Finnishnot grpmax-eligible | 0.103% | 970 |
| African / African-American | 0.0626% | 1,597 |
| Ashkenazi Jewishnot grpmax-eligible | 0.0101% | 9,869 |
| South Asian | 0.0011% | 91,072 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NPHP3
- Protein
- p.Asn386Ser
- Coding
- c.1157A>G
- MANE Select
- NM_153240
- dbSNP
- rs142021049
- Type
- single nucleotide variant
- Location
- chr3:132708219 (GRCh38)
- Gene constraint
- LOEUF 0.873 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 73.59 · 1 PDB
- Residue 386
- a UniProt-annotated variant site (in nphp3)
Disease context
nephronophthisis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: renal-hepatic-pancreatic dysplasia 1NPHP3-related Meckel-like syndromenephronophthisis 3
For Nephronophthisis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 100 000 (Finland)
Similar variants
- NPHP3 p.Asn386= Likely benign ★ same residue
- NPHP3 p.Asn386fs Likely pathogenic ★ same residue
- NPHP3 c.1985+1G>A Pathogenic/Likely pathogenic ★★ same condition
- NPHP3 c.3201+1G>T Likely pathogenic ★★ same condition
- NPHP3 c.393+1G>C Likely pathogenic ★★ same condition
- NPHP3 c.520-1G>T Pathogenic ★★ same condition
- NPHP3 c.823+1G>T Likely pathogenic ★★ same condition
- NPHP3 c.958-2A>G Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nphp3-p-asn386ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown